Veeva Systems Inc. – Consensus ‘buy’ rating and .9% Upside Potential

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Veeva Systems Inc. which can be found using ticker (VEEV) have now 23 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The range between the high target price and low target price is between 247 and 181 and has a mean target at $221.74. Given that the stocks previous close was at $219.85 this would imply there is now a potential upside of .9%. Also worth taking note is the 50 day moving average now sits at $198.41 and the 200 moving average now moves to $181.13. The market capitalization for the company is 35.74B. The current share price for the company is: 222.47 USD

The potential market cap would be $36,048,397,314 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 61.8, revenue per share of 14.12 and a 5.3% return on assets.

Veeva Systems Inc. is a provider of industry cloud solutions for the global life sciences industry. The Company’s offerings span cloud software, data, and business consulting and are designed to meet the needs of its customers and their most strategic business functions from research and development (R&D) to commercialization. The Company’s industry cloud solutions for the life sciences industry are grouped into two major product families: Veeva Development Cloud and Veeva Commercial Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its proprietary Veeva Vault platform. Veeva Commercial Cloud includes solutions for the sales, medical affairs, and marketing functions of a life sciences company. Its software offerings include Veeva CRM, Veeva Vault PromoMats, Veeva Vault Medical, and Veeva Crossix. Its data offerings include Veeva OpenData, Veeva Link, and Veeva Compass.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search